MoneyHero Group Successfully Completes Business Combination with Bridgetown Holdings Limited 13-10-2023, 06:00

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa 15-10-2023, 20:03

Jesse Gary, Century’s President and CEO, to participate in 23-02-2023, 06:15